ANAPTYSBIO INC
ANABLatest QuantConomy context for ANAB: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
ANAPTYSBIO INC
QuantConomy has a structured record for ANAB. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ANAB
- Name
- ANAPTYSBIO INC
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq lse
Recent signals for ANAB
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| revenue change | very bearish | 76 | Jul 11, 12:00 AM | ANAB (Q1 2026, revenue): declined 89.1% ($234.60M → $25.56M). [sequential period basis, very bearish signal] |
| net income change | very bearish | 76 | Jul 11, 12:00 AM | ANAB (Q1 2026, net income): declined 299.7% (-$13.23M → -$52.88M). [sequential period basis, very bearish signal] |
| eps change | very bearish | 76 | Jul 11, 12:00 AM | ANAB (Q1 2026, diluted eps): EPS declined 300.0% ($-0.46 → $-1.84). [sequential period basis, very bearish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ANAB | NASDAQ | alphavantage | AnaptysBio Inc |
| ANAB | NASDAQ | alpaca | AnaptysBio, Inc. Common Stock |
| ANAB | NASDAQ | fmp | AnaptysBio, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | Murphy Christopher M. | Chief Financial Officer | grant | 25,765 | — | — | 4 on EDGAR |
| May 11, 2026 | Hughes Owen | Director | grant | 11,250 | — | — | 4 on EDGAR |
| Apr 27, 2026 | GRAY SUSANNAH | Director | grant | 11,250 | — | — | 4 on EDGAR |
| Apr 20, 2026 | Schmid John P. | Director | other | 15,000 | — | — | 4 on EDGAR |
| Apr 20, 2026 | Orwin John A | Director | other | 3,311 | — | — | 4 on EDGAR |
| Apr 20, 2026 | Faga Daniel | President, CEO | other | 11,000 | — | — | 4 on EDGAR |
| Apr 20, 2026 | Faga Daniel | President, CEO | other | 11,000 | — | — | 4 on EDGAR |
| Apr 20, 2026 | RENTON HOLLINGS | Director | other | 15,000 | — | — | 4 on EDGAR |
| Mar 30, 2026 | Schmid John P. | Director | sale | 12,596 | $55.71 | $701,707 | 4 on EDGAR |
| Mar 25, 2026 | Faga Daniel | President, CEO | grant | 34,300 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query ANAB context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access